摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

O,O'-bis(trimethylsilyl)-5-benzyloxymethyluracil | 98808-20-9

中文名称
——
中文别名
——
英文名称
O,O'-bis(trimethylsilyl)-5-benzyloxymethyluracil
英文别名
silylated 5-benzyloxymethyl uracil;5-benzyloxymethyl-2,4-bis-trimethylsilanyloxy-pyrimidine;5-[(Benzyloxy)methyl]-2,4-bis[(trimethylsilyl)oxy]pyrimidine;trimethyl-[5-(phenylmethoxymethyl)-2-trimethylsilyloxypyrimidin-4-yl]oxysilane
O,O'-bis(trimethylsilyl)-5-benzyloxymethyluracil化学式
CAS
98808-20-9
化学式
C18H28N2O3Si2
mdl
——
分子量
376.603
InChiKey
AGKDZTUEUUXLMD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    412.7±55.0 °C(Predicted)
  • 密度:
    1.042±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.62
  • 重原子数:
    25
  • 可旋转键数:
    8
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.44
  • 拓扑面积:
    53.5
  • 氢给体数:
    0
  • 氢受体数:
    5

SDS

SDS:951aca081037b04ec940d8a2c292be45
查看

反应信息

点击查看最新优质反应信息

文献信息

  • Uracil derivatives. V. Syntheses and growth-inhibitory activity against L-1210 cells of 5-substituted 2'-deoxyuridines and orotidine derivatives.
    作者:JUTARO OKADA、KOICHI NAKANO、HIROSHI MIYAKE
    DOI:10.1248/cpb.33.856
    日期:——
    5-Benzyloxymethyl-2'-deoxyuridine 3', 5'-di-p-toluate (III), a key intermediate in the preparation of 5-substituted 2'-deoxyuridines (VIa-d), was prepared in satisfactory yield. 5-(4-Substituted phenylthiomethyl)-2'-deoxyuridines (VIa-d) were synthesized in three steps from III. The reaction of silylated orotates (VIIa-e) with 1-O-acetyl-2, 3, 5-tri-O-benzoyl-β-D-ribofuranose (VIII) gave the N1, N3-bisribosides (IXa-e) and the N3-ribosides (Xa-e). The N3-ribosides (Xa-e) were deprotected to give the N3-nucleosides (XIa-e). Compounds VIa-d and XIa-e were tested for ability to inhibit the growth of L-1210 cells in vitro.
    5-苄氧基甲基-2'-脱氧尿苷3', 5'-二对甲苯甲酸酯(III)是制备5-取代的2'-脱氧尿苷(VIa-d)的关键中间体,其收率令人满意。从III开始分三个步骤合成5-(4-取代的苯硫基甲基)-2'-脱氧尿苷(VIa-d)。甲硅烷基化乳清酸酯(VIIa-e)与1-O-乙酰基-2,3,5-三-O-苯甲酰基-β-D-呋喃核糖(VIII)反应得到N1,N3-双核糖苷(IXa-e)和N3-核苷(Xa-e)。将N3-核苷(Xa-e)去保护以得到N3-核苷(XIa-e)。测试了化合物VIa-d和XIa-e在体外抑制L-1210细胞生长的能力。
  • Synthesis of 5-Alkoxymethyl Derivatives of 3'-Amino-2',3'-dideoxyuridine and Evaluation of their Activity against HIV and Cancer.
    作者:Mohammed S. Motawia、Ahmed E. S. Abdel-Megied、Erik B. Pedersen、Carsten M. Nielsen、Peter Ebbesen、Daniel R. Carcanague、Ito Chao、K. N. Houk
    DOI:10.3891/acta.chem.scand.46-0077
    日期:——
    3-dideoxy-beta- D-erythro-pentofuranose (3), in the presence of trimethylsilyl triflate as a catalyst, to give the corresponding 3'-phthalimido-2',3'-dideoxynucleosides 5a-f and 6 which on treatment with 33% methylamine-ethanol afforded the corresponding 3'-amino-2',3'-dideoxynucleosides 7a-f and 8 in high yields. Compound 7d showed colony inhibition when tested against human epidermoid cervical cancer cells
    5-烷氧基甲基尿嘧啶2a-c已通过5-羟基甲基尿嘧啶(1)的酸催化醚化反应制备。将化合物1、2a-c,5-甲氧基甲基-和5-苄氧基甲基-尿嘧啶甲硅烷基化并与1,5-二-O-乙酰基-3-邻苯二甲酰亚胺基-2,3-二脱氧-β-D-赤型戊呋喃糖( 3),在三氟甲磺酸三甲基甲硅烷基酯作为催化剂的存在下,得到相应的3'-邻苯二甲酰亚胺基-2',3'-二脱氧核苷5a-f和6,将其用33%甲胺-乙醇处理后得到相应的3'-氨基-2',3'-二脱氧核苷7a-f和8的产量很高。当针对人表皮样宫颈癌细胞进行测试时,化合物7d显示出集落抑制作用。核苷5a-e,7a-f和8没有显示出对HIV-1的任何显着活性。
  • Synthesis of 2?,3?-dideoxynucleosides from 5-alkoxymethyluracils
    作者:Ahmed E. -S. Abdel-Megied、Erik B. Pedersen、Carsten M. Nielsen
    DOI:10.1007/bf00815166
    日期:——
    A modified synthesis of protected 2,3-dideoxyribose 5 starting from L-glutamic acid (1) is described. Reaction of 5 with silylated 5-hydroxymethyluracil 7 a and 5-alkoxymethyluracils 7 b-e in the presence of trimethylsilyl triflate afforded an anomeric mixture of 2',3'-dideoxyuridine derivatives 8 a-e and 9 a-e. Deprotection with methanolic ammonia and separation by chromatography gave the corresponding nucleosides 10 a-e and 11 a-e. Treatment of 9 b-e with tri(1H-1,2,4-triazol-1-yl) phosphine oxide and subsequent reaction of 12 b-e with ammonia in dioxane afforded the cytosine derivatives 13 b-e which on treatment with methanolic ammonia gave the corresponding 2',3'-dideoxycytidine derivatives 14 b-e and 15 b-e. In contrast with the parent compounds, these alkoxymethyl derivatives had no appreciable activity against human immunodeficiency virus (HIV-1).
  • Megied, Ahmed E.-S. Abdel; Ali, Omar M.; Kofoed, Thomas, Nucleosides and nucleotides, 2001, vol. 20, # 1-2, p. 1 - 10
    作者:Megied, Ahmed E.-S. Abdel、Ali, Omar M.、Kofoed, Thomas、Pedersen, Erik B.
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐